A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)
Clinical trial NCT01213316 · COMPLETED
Trial details
- NCT number
- NCT01213316
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-10-01
- Primary completion
- 2015-04-01
- Enrollment
- 451
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.